Risk-factors of melphalan/fludarabine dose-reduced allogeneic stem cell transplantation in patients with multiple myelomaN. Kroger,J.A. Perez-Simon,H. Myint,H. Klingemann,A. Shimoni,A. Nagler,R. Martino,A. Allegre,J. Tomas,R. Schwerdtfeger, M. Kiehl,A. Fauser,H.G. Sayer,A. Leon, J. Beyer,T. Zabelina,F. Ayuk,J. San Miguel,R. Brand,A. ZanderBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION（2004）引用 3|浏览9暂无评分关键词risk factorsAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
